Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Multicenter Study Evaluating 200 Mg Versus 600 Mg of Mifegyne® on Pain in Medical Termination of Pregnancy (MToP) Up to 7 Weeks of Amenorreha (WA). DoMy Study.

NCT03659045 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT03659045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03659045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Multicenter Study Evaluating 200 Mg Versus 600 Mg of Mifegyne® on Pain in Medical Termination of Pregnancy (MToP) Up to 7 Weeks of Amenorreha (WA). DoMy Study.
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2019
Completion date
April 4, 2023
Enrollment
320 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

abortion-related disorders